These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8140339)

  • 21. Extracorporeal treatments in sepsis: are there new perspectives?
    Tetta C; D'Intini V; Bellomo R; Bonello M; Bordoni V; Ricci Z; Ronco C
    Clin Nephrol; 2003 Nov; 60(5):299-304. PubMed ID: 14640234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Severe sepsis as a cause of acute renal failure].
    Díaz de León M; Moreno SA; González Díaz DJ; Briones GJ
    Nefrologia; 2006; 26(4):439-44. PubMed ID: 17058855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathogenesis and therapeutic strategy].
    Schulze D
    Med Monatsschr Pharm; 2005 Jul; 28(7):246-8. PubMed ID: 16038124
    [No Abstract]   [Full Text] [Related]  

  • 24. Endothelins in hypertension and kidney diseases.
    Ivić MA; Stefanović V
    Pathol Biol (Paris); 1998 Nov; 46(9):723-30. PubMed ID: 9885830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acute renal failure in sepsis. Strategies for prevention].
    Hausmann R
    Aktuelle Urol; 2005 Jun; 36(3):188-94. PubMed ID: 16001335
    [No Abstract]   [Full Text] [Related]  

  • 26. Continuous renal replacement therapy in sepsis and multisystem organ failure.
    Joannidis M
    Semin Dial; 2009; 22(2):160-4. PubMed ID: 19426421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal-dose (low-dose) dopamine for the treatment of sepsis-related and other forms of acute renal failure: ineffective and probably dangerous.
    Power DA; Duggan J; Brady HR
    Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S23-8. PubMed ID: 10386250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cysteinyl-leukotriene receptors in pulmonary vessels.
    Walch L; Norel X; Gascard JP; Brink C
    J Physiol Pharmacol; 1999 Dec; 50(4):567-73. PubMed ID: 10639007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelin and nitric oxide in hepatorenal syndrome: a balance reset.
    Epstein M; Goligorsky MS
    J Nephrol; 1997; 10(3):120-35. PubMed ID: 9238620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maximizing renal preservation in acute renal failure.
    Dudley C
    BJU Int; 2004 Nov; 94(8):1202-6. PubMed ID: 15613164
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of endothelin and endothelin receptor antagonists in renal disease.
    Neuhofer W; Pittrow D
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():78-88. PubMed ID: 16919017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric critical care management of septic shock prior to acute kidney injury and renal replacement therapy.
    Fortenberry JD
    Semin Nephrol; 2008 Sep; 28(5):447-56. PubMed ID: 18790364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluid resuscitation and the septic kidney.
    Bagshaw SM; Bellomo R
    Curr Opin Crit Care; 2006 Dec; 12(6):527-30. PubMed ID: 17077681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of the heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury model.
    Villar J; Ribeiro SP; Mullen JB; Kuliszewski M; Post M; Slutsky AS
    Crit Care Med; 1994 Jun; 22(6):914-21. PubMed ID: 8205824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiology of septic acute kidney injury: what do we really know?
    Wan L; Bagshaw SM; Langenberg C; Saotome T; May C; Bellomo R
    Crit Care Med; 2008 Apr; 36(4 Suppl):S198-203. PubMed ID: 18382194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukotrienes as mediators in diseases of the liver.
    Keppler D; Huber M; Baumert T
    Semin Liver Dis; 1988 Nov; 8(4):357-66. PubMed ID: 3062791
    [No Abstract]   [Full Text] [Related]  

  • 37. Novel mediators of sepsis-associated renal failure.
    Badr KF
    Semin Nephrol; 1994 Jan; 14(1):3-7. PubMed ID: 8140339
    [No Abstract]   [Full Text] [Related]  

  • 38. Sepsis-associated renal vasoconstriction: potential targets for future therapy.
    Badr KF
    Am J Kidney Dis; 1992 Sep; 20(3):207-13. PubMed ID: 1519601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of soluble mediators in sepsis and renal failure.
    Camussi G; Ronco C; Montrucchio G; Piccoli G
    Kidney Int Suppl; 1998 May; 66():S38-42. PubMed ID: 9573571
    [No Abstract]   [Full Text] [Related]  

  • 40. [The role of thromboxane A2 in shock. I. Endotoxic shock].
    Fukushige T
    Masui; 1986 Mar; 35(3):422-7. PubMed ID: 3712740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.